Intrinsic Value of S&P & Nasdaq Contact Us

Allied Corp. ALID OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
17/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Allied Corp. (ALID) is a publicly traded company in the Healthcare sector, operating within the Drug Manufacturers - Specialty & Generic industry. The company is headquartered in Kelowna, BC, Canada. The current CEO is Paul Bullock.

ALID has IPO date of 2019-08-15, 150 full-time employees, listed on the Other OTC, a market capitalization of $57.75K.

About Allied Corp.

Allied Corp., a medical cannabis production company, engages in the research, development, and production of cannabinoid health solutions in the United States. It offers hemp-derived natural health products, including Liberty, a hemp-derived cannabidiol (CBD) tincture; Tactical Hydration, a CBD infused electrolyte replacement drink; FIZZ Tablets for adding in a water bottle; Battle Balm, a CBD roll on activity rub for aches and pains; and Quick Hit, a CBD gummy under the Tactical Relief brand. The company also provides Hydrosport CBD Drink, a CBD infused electrolyte replacement drink with sodium citrate electrolyte replacement; Hydrosport Tincture, a CBD tincture fortified with specific terpene profile; FIZZ Tablets for adding to a water bottle; Sport Rub, a CBD post-activity rub for aches and pains; and Quick Hit, a CBD gummy with vitamin B12 under the Equilibrium Bio brand. In addition, it offers Skin Structure, a facial formula topically applied to enhance skin's radiance and youthfulness; Eye Recover that helps the eye skin ward off free radicals, as well as helping to protect against sun damage; Glossy Lip Recover, which moisturizes and nourishes lips; Skin Designer that stimulates cell regeneration while minimizing age spots; Vitamin Absolute, a moisturizing facial oil; and Absolute Recover, a formulation that allows the infused bioactive compounds to be delivered directly to the desired areas of inflammation, pain, and other skin ailments under the MaXXa brand. In addition, it is developing ALID 10 and ALID 11, a pharma product, which is in Phase I clinical trial for treating post-traumatic stress disorder. The company was incorporated in 2013 and is headquartered in Kelowna, Canada.

📍 1405 St. Paul Street, Kelowna, BC V1Y 2E4 📞 877 255 4337
Company Details
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryCanada
ExchangeOther OTC
CurrencyUSD
IPO Date2019-08-15
CEOPaul Bullock
Employees150
Trading Info
Current Price$0.00
Market Cap$57.75K
52-Week Range0.0005-0.02555
Beta-0.83
ETFNo
ADRNo
CUSIP019114107
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message